- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
Novo Nordisk A/S at JPMorgan CEO Call Series Transcript
Good morning, good afternoon to everyone. A warm welcome from my side, and thanks very much for joining us in the 11th installment of our CEO call series, and today, that's with Novo Nordisk. It's our great pleasure to welcome the CEO of Novo Nordisk, Lars Fruergaard Jorgensen, who is going to speak with us today.
So before I hand over to Lars for a few introductory remarks, I'd just remind everyone that this is primarily a call for your questions. So I'll ask a few questions upfront, but please feel free at any time to ask a question. (Operator Instructions)
With that, I'd like to say thanks very much to Lars for joining us today and hand over to him for a few introductory remarks. Lars, welcome.
/- -
Thank you very much, Richard, and thanks for hosting us today. It's exciting times in Novo Nordisk. We are making good progress on all of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |